Here, we show that cytotoxicity of the TRAIL-expressing oncolytic adenovirus AdV-TRAIL can be significantly improved in TRAIL-resistant and TRAIL-sensitive melanoma cell lines by silencing of the antiapoptotic Bcl-2 protein Mcl-1. The gene discussed is TNFSF10; the disease is melanoma.